# Ananya Choudhury

Source: https://onco.cc/people/ananya-choudhury/  
OnCo record `ananya-choudhury` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Ananya Choudhury is a clinical oncologist developing biomarker-guided radiotherapy for bladder cancer.

## Summary

Ananya Choudhury is Professor of Clinical Oncology at the University of Manchester and a consultant at The Christie NHS Foundation Trust. Her specialisms are bladder cancer radiotherapy, hypoxia biomarkers and radiobiology, using modern image-guided external beam techniques. She is known for developing biomarker-guided radiotherapy for bladder cancer, including hypoxia signatures that select patients for radiosensitisation. Her papers include an individual patient data meta-analysis of hypofractionated radiotherapy in the BC2001 and BCON trials, a phase II study of hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer, and a study of pre-treatment lymphocytopaenia as an adverse prognostic marker. Her publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Clinical Oncology, University of Manchester; Consultant, The Christie
- Specialisms: Bladder cancer radiotherapy; Hypoxia biomarkers; Radiobiology

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Choudhury%20A%5BAuthor%5D%20bladder%20radiotherapy%20hypoxia

## Connected records

- cancers: [Bladder & urothelial cancer](https://onco.cc/cancers/urothelial/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- institutions: [The Christie NHS Foundation Trust](https://onco.cc/institutions/the-christie/)
- ideas: [Core-funded radiotherapy trials infrastructure with central quality assurance](https://onco.cc/ideas/idea-fund-radiotherapy-trials-infrastructure/)

---
JSON: https://onco.cc/api/v1/entities/ananya-choudhury.json